Dihydroxybenzoic acid isomers differentially dissociate soluble biotinyl-Aβ(1-42) oligomers

Biochemistry

Volumn 51, Issue 1, 2012, Pages 307-315

  Le Vine, Harry ^a   Lampe, Levi ^a   Abdelmoti, Lina ^a   Augelli Szafran, Corinne E ^b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b Brigham and Women's Hospital Center for Neurologic Diseases   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 ,4-DIHYDROXYBENZOIC ACIDS; ACTIVE COMPOUNDS; AROMATIC RINGS; BENZOIC ACID; BENZOIC ACID DERIVATIVES; BLOCK OLIGOMERS; CATECHIN DERIVATIVES; CURCUMIN; DIHYDROXYBENZOIC ACIDS; FIBRIL MORPHOLOGY; GALLIC ACIDS; INTRINSIC DISSOCIATION; LEAD STRUCTURE; MECHANISM OF ACTION; MONOMER DISSOCIATION; NATURAL PRODUCTS; NORDIHYDROGUAIARETIC ACID; OLIGOMER STRUCTURE; POLYPHENOLIC COMPOUND; REDOX CYCLING; RESVERATROL; SMALL MOLECULES;

CARBOXYLIC ACIDS; CATALYTIC OXIDATION; DISSOCIATION; DYES; ISOMERS; MONOMERS; PHENOLS;

OLIGOMERS;

2,3 DIHYDROXYBENZOIC ACID; AMYLOID BETA PROTEIN[1-42]; CATECHIN; CURCUMIN; EPIGALLOCATECHIN GALLATE; GALLIC ACID; GENTISIC ACID; NORDIHYDROGUAIARETIC ACID; OLIGOMER; PROTOCATECHUIC ACID; RESVERATROL;

ARTICLE; DRUG EFFECT; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN ASSEMBLY; PROTEIN STRUCTURE;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; BENZOIC ACID; BIOTINYLATION; CATECHOLS; DOPAMINE; GLUTARAL; HUMANS; ISOMERISM; PEPTIDE FRAGMENTS; PROTEOLYSIS; SOLUBILITY;

EID: 84856813248     PISSN: 00062960     EISSN: 15204995     Source Type: Journal    
DOI: 10.1021/bi201288x     Document Type: Article

References (24)

1. Lambert, M. P., Barlow, A. K., Chromy, B. A., Edwards, C., Freed, R., Liosatos, M., Morgan, T. E., Rozovsky, I., Trommer, B., Viola, K. L., Wals, P., Zhang, C., Finch, C. E., Krafft, G. A., and Klein, W. L. (1998) Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. Proc. Natl. Acad. Sci. U. S. A. 95, 6448-6453.
2. Hong, H. S., Maezawa, I., Yao, N., Xu, B., Diaz-Avalos, R., Rana, S., Hua, D. H., Cheng, R. H., Lam, K. S., and Jin, L. W. (2007) Combining the rapid MTT formazan exocytosis assay and the MC65 protection assay led to the discovery of carbazole analogs as small molecule inhibitors of Abeta oligomer-induced cytotoxicity. Brain Res. 1130, 223-234. (Pubitemid 46075114)
3. Glabe, C. G. (2008) Structural classification of toxic amyloid oligomers. J. Biol. Chem. 283, 29639-29643.
4. Malchiodi-Albedi, F., Paradisi, S., Matteucci, A., Frank, C., and Diociaiuti, M. (2011) Amyloid oligomer neurotoxicity, calcium dysregulation, and lipid rafts. Int. J. Alzheimer's Dis. 2011, 906964.
5. Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., and Selkoe, D. J. (2002) Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal longterm potentiation in vivo. Nature 416, 535-539. (Pubitemid 34288854)
6. Selkoe, D. J. (2008) Soluble oligomers of the amyloid betaprotein impair synaptic plasticity and behavior. Behav. Brain Res. 192, 106-113.
7. Fa M., Orozco, I. J., Francis, Y. I., Saeed, F., Gong, Y., and Arancio, O. (2010) Preparation of oligomeric beta-amyloid 1-42 and induction of synaptic plasticity impairment on hippocampal slices. J. Vis. Exp., DOI: DOI:10.3791/1884.
8. Ondrejcak, T., Klyubin, I., Hu, N. W., Barry, A. E., Cullen, W. K., and Rowan, M. J. (2009) Alzheimer's Disease Amyloid beta-Protein and Synaptic Function. NeuroMol. Med. 12, 13-26.
9. De Felice, F. G., Vieira, M. N., Saraiva, L. M., Figueroa-Villar, J. D., Garcia-Abreu, J., Liu, R., Chang, L., Klein, W. L., and Ferreira, S. T. (2004) Targeting the neurotoxic species in Alzheimer's disease: inhibitors of Abeta oligomerization. FASEB J. 18, 1366-1372. (Pubitemid 39150351)
10. Necula, M., Kayed, R., Milton, S., and Glabe, C. G. (2007) Small-molecule inhibitors of aggregation indicate that amyloid beta oligomerization and fibrillization pathways are independent and distinct. J. Biol. Chem. 282, 10311-10324. (Pubitemid 47093410)
11. Look, G. C., Jerecic, J., Cherbavaz, D. B., Pray, T. R., Breach, J. C., Crosier, W. J., Igoudin, L., Hironaka, C. M., Lowe, R. M., McEntee, M., Ruslim-Litrus, L., Wu, H. M., Zhang, S., Catalano, S. M., Goure, W. F., Summa, D., and Krafft, G. A. (2007) Discovery of ADDL-targeting small molecule drugs for Alzheimer's disease. Curr. Alzheimer Res. 4, 562-567. (Pubitemid 350248392)
12. Kawasaki, T., Onodera, K., and Kamijo, S. (2010) Selection of Peptide inhibitors of soluble abeta(1-42) oligomer formation by phage display. Biosci., Biotechnol., Biochem. 74, 2214-2219.
13. Reinke, A. A., Seh, H. Y., and Gestwicki, J. E. (2009) A chemical screening approach reveals that indole fluorescence is quenched by pre-fibrillar but not fibrillar amyloid-beta. Bioorg. Med. Chem. Lett. 19, 4952-4957.
14. Walsh, D. M., Townsend, M., Podlisny, M. B., Shankar, G. M., Fadeeva, J. V., Agnaf, O. E., Hartley, D. M., and Selkoe, D. J. (2005) Certain inhibitors of synthetic amyloid beta-peptide (Abeta) fibrillogenesis block oligomerization of natural Abeta and thereby rescue long-term potentiation. J. Neurosci. 25, 2455-2462. (Pubitemid 40365155)
15. LeVine, H. III (2006) Biotin-avidin interaction-based screening assay for Alzheimer's beta-peptide oligomer inhibitors. Anal. Biochem. 356, 265-272.
16. LeVine, H. III, Ding, Q., Walker, J. A., Voss, R. S., and Augelli-Szafran, C. E. (2009) Clioquinol and other hydroxyquinoline derivatives inhibit Abeta(1-42) oligomer assembly. Neurosci. Lett. 465, 99-103.
17. LeVine, H. III (2004) Alzheimer's beta-peptide oligomer formation at physiologic concentrations. Anal. Biochem. 335, 81-90.
18. Murphy, M. P., Beckett, T. L., Ding, Q., Patel, E., Markesbery, W. R., St Clair, D. K., LeVine, H. III, and Keller, J. N. (2007) Abeta solubility and deposition during AD progression and in APPxPS-1 knock-in mice. Neurobiol. Dis. 27, 301-311. (Pubitemid 47333189)
19. Fluckiger, R., Paz, M. A., and Gallop, P. M. (1995) Redoxcycling detection of dialyzable pyrroloquinoline quinone and quinoproteins. Methods Enzymol. 258, 140-149.
20. Di Giovanni, S., Eleuteri, S., Paleologou, K. E., Yin, G., Zweckstetter, M., Carrupt, P. A., and Lashuel, H. A. (2010) Entacapone and tolcapone, two catechol O-methyltransferase inhibitors, block fibril formation of alpha-synuclein and beta-amyloid and protect against amyloid-induced toxicity. J. Biol. Chem. 285, 14941-14954.
21. Ladiwala, A. R., Dordick, J. S., and Tessier, P. M. (2010) Aromatic small molecules remodel toxic soluble oligomers of amyloid {beta} through three independent pathways. J. Biol. Chem. 285, 24228-24237.
22. Ehrnhoefer, D. E., Bieschke, J., Boeddrich, A., Herbst, M., Masino, L., Lurz, R., Engemann, S., Pastore, A., and Wanker, E. E. (2008) EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers. Nat. Struct. Mol. Biol. 15, 558-566. (Pubitemid 351799141)
23. Bieschke, J., Russ, J., Friedrich, R. P., Ehrnhoefer, D. E., Wobst, H., Neugebauer, K., and Wanker, E. E. (2010) EGCG remodels mature alpha-synuclein and amyloid-beta fibrils and reduces cellular toxicity. Proc. Natl. Acad. Sci. U. S. A. 107, 7710-7715.
24. Lesne, S., Koh, M. T., Kotilinek, L., Kayed, R., Glabe, C. G., Yang, A., Gallagher, M., and Ashe, K. H. (2006) A specific amyloidbeta protein assembly in the brain impairs memory. Nature 440, 352-357.